13G Filing: Stonepine Capital Management, LLC Details Ownership of Vanda Pharmaceuticals Inc. (VNDA)

Page 5 of 8 SEC Filing

Names of Reporting Persons.

Timothy P. Lynch

2. Check the Appropriate Box if
a Member of a Group (See Instructions)

(a) ______

(b) X

3. SEC Use Only

4. Citizenship or Place of Organization
U.S.A.

Number of

Shares

Beneficially

Owned by

Each Reporting

Person With:

5. Sole Voting Power 2,017,900

6. Shared Voting Power 0

7. Sole Dispositive Power 2,017,900
8. Shared Dispositive Power 0

9. Aggregate Amount Beneficially
Owned by Each Reporting Person 2,017,900

10. Check if the Aggregate Amount
in Row (9) Excludes Certain Shares (See
Instructions) ______

11. Percent of Class Represented
by Amount in Row (9) 4.7%

12. Type of Reporting Person (See
Instructions) HC, IN

5

Follow Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)